Teleflex Inkomsten in het verleden
Verleden criteriumcontroles 1/6
De winst van Teleflex is gedaald met een gemiddeld jaarlijks percentage van -7.9%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 12.3%. De inkomsten zijn groeide met een gemiddeld percentage van 3.9% per jaar. Het rendement op het eigen vermogen Teleflex bedraagt 5.3% en de nettomarge bedraagt 7.9%.
Belangrijke informatie
-7.9%
Groei van de winst
-8.3%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 3.9% |
| Rendement op eigen vermogen | 5.3% |
| Nettomarge | 7.9% |
| Laatste winstupdate | 29 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?
Sep 30
Returns On Capital At Teleflex (NYSE:TFX) Paint A Concerning Picture
Sep 14Market Participants Recognise Teleflex Incorporated's (NYSE:TFX) Earnings
Aug 29Teleflex Reinvesting In Growth, But Valuation Isn't That Compelling
Aug 26Is Teleflex Incorporated (NYSE:TFX) Potentially Undervalued?
Jul 29Here's Why Teleflex (NYSE:TFX) Can Manage Its Debt Responsibly
Jun 20Investors Could Be Concerned With Teleflex's (NYSE:TFX) Returns On Capital
Jun 05Is Teleflex Incorporated (NYSE:TFX) Trading At A 39% Discount?
May 21Teleflex: Compelling, Despite Some Operational Hiccups
May 06What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?
Apr 21Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Mar 06Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate
Feb 19Is Teleflex (NYSE:TFX) A Risky Investment?
Feb 02Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult
Jan 17Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Dec 31Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Nov 13We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt
Oct 29Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Oct 13Teleflex Shares Hit Hard As Growth Concerns Stack Up
Oct 13Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?
Sep 27Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return
Aug 07Teleflex: Flexing Its Muscles A Bit
Jul 27Is Teleflex (NYSE:TFX) A Risky Investment?
Jul 20Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price
Jul 05Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings
Jun 22What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Jun 20Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger
May 05These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well
Apr 17Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Mar 31At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?
Mar 14Teleflex's 2 catheter devices get FDA clearance
Feb 22Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns
Jan 27Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet
Jan 12Teleflex Already Getting A Pretty Good Benefit Of The Doubt
Jan 11An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued
Dec 28What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Dec 12Teleflex recalls over 2.7M bacterial filters – FDA
Nov 01Opbrengsten en kosten
Hoe Teleflex geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 29 Sep 24 | 3,026 | 238 | 1,195 | 153 |
| 30 Jun 24 | 3,008 | 265 | 1,154 | 152 |
| 31 Mar 24 | 3,001 | 296 | 1,141 | 150 |
| 31 Dec 23 | 2,974 | 358 | 991 | 154 |
| 01 Oct 23 | 2,959 | 405 | 907 | 161 |
| 02 Jul 23 | 2,899 | 369 | 904 | 161 |
| 02 Apr 23 | 2,860 | 363 | 888 | 159 |
| 31 Dec 22 | 2,791 | 363 | 861 | 154 |
| 25 Sep 22 | 2,795 | 412 | 862 | 147 |
| 26 Jun 22 | 2,808 | 510 | 856 | 141 |
| 27 Mar 22 | 2,817 | 488 | 859 | 137 |
| 31 Dec 21 | 2,810 | 485 | 852 | 131 |
| 26 Sep 21 | 2,759 | 434 | 836 | 129 |
| 27 Jun 21 | 2,687 | 351 | 829 | 126 |
| 28 Mar 21 | 2,540 | 280 | 784 | 122 |
| 31 Dec 20 | 2,537 | 336 | 782 | 120 |
| 27 Sep 20 | 2,507 | 367 | 772 | 117 |
| 28 Jun 20 | 2,527 | 479 | 770 | 116 |
| 29 Mar 20 | 2,612 | 551 | 798 | 114 |
| 31 Dec 19 | 2,595 | 462 | 798 | 114 |
| 29 Sep 19 | 2,556 | 442 | 804 | 111 |
| 30 Jun 19 | 2,517 | 269 | 812 | 109 |
| 31 Mar 19 | 2,475 | 183 | 814 | 107 |
| 31 Dec 18 | 2,448 | 196 | 744 | 106 |
| 30 Sep 18 | 2,402 | 66 | 822 | 104 |
| 01 Jul 18 | 2,327 | 89 | 784 | 99 |
| 01 Apr 18 | 2,246 | 170 | 738 | 93 |
| 31 Dec 17 | 2,146 | 155 | 696 | 85 |
| 01 Oct 17 | 2,065 | 259 | 634 | 75 |
| 02 Jul 17 | 1,986 | 246 | 611 | 69 |
| 02 Apr 17 | 1,931 | 227 | 594 | 64 |
| 31 Dec 16 | 1,868 | 237 | 570 | 59 |
| 25 Sep 16 | 1,828 | 267 | 569 | 56 |
| 26 Jun 16 | 1,816 | 262 | 569 | 54 |
| 27 Mar 16 | 1,795 | 248 | 568 | 52 |
| 31 Dec 15 | 1,799 | 236 | 574 | 52 |
| 27 Sep 15 | 1,798 | 197 | 578 | 56 |
| 28 Jun 15 | 1,808 | 191 | 577 | 58 |
| 29 Mar 15 | 1,821 | 194 | 586 | 60 |
| 31 Dec 14 | 1,827 | 190 | 586 | 61 |
| 28 Sep 14 | 1,802 | 174 | 573 | 62 |
| 29 Jun 14 | 1,759 | 164 | 554 | 62 |
| 30 Mar 14 | 1,711 | 159 | 526 | 64 |
| 31 Dec 13 | 1,685 | 151 | 502 | 65 |
Kwaliteitswinsten: TFX heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (7.9%) TFX } zijn lager dan vorig jaar (13.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van TFX is de afgelopen 5 jaar met 7.9% per jaar gedaald.
Versnelling van de groei: De winstgroei TFX is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: TFX had het afgelopen jaar een negatieve winstgroei ( -41% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 11.5% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 5.3% ) van TFX wordt als laag beschouwd.